搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Lawsonia intracellularis Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP630924LAAL
CSB-EP630924LAAL
CSB-BP630924LAAL
CSB-MP630924LAAL
CSB-EP630924LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP630925LAAL
CSB-EP630925LAAL
CSB-BP630925LAAL
CSB-MP630925LAAL
CSB-EP630925LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Ribonuclease HII (rnhB) CSB-YP630926LAAL
CSB-EP630926LAAL
CSB-BP630926LAAL
CSB-MP630926LAAL
CSB-EP630926LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Phosphate acyltransferase (plsX) CSB-YP630927LAAL
CSB-EP630927LAAL
CSB-BP630927LAAL
CSB-MP630927LAAL
CSB-EP630927LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Enolase (eno) CSB-YP630928LAAL
CSB-EP630928LAAL
CSB-BP630928LAAL
CSB-MP630928LAAL
CSB-EP630928LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Peptide chain release factor 1 (prfA) CSB-YP630929LAAL
CSB-EP630929LAAL
CSB-BP630929LAAL
CSB-MP630929LAAL
CSB-EP630929LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe THP3 homolog C2A9.11c (SPBC2A9.11c, SPBC2D10.01c) CSB-YP630930SXV
CSB-EP630930SXV
CSB-BP630930SXV
CSB-MP630930SXV
CSB-EP630930SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe RNA-binding protein with serine-rich domain 1 homolog (SPBC13G1.14c) CSB-YP630931SXV
CSB-EP630931SXV
CSB-BP630931SXV
CSB-MP630931SXV
CSB-EP630931SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lagorchestes hirsutus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP630932LAAS1
CSB-EP630932LAAS1
CSB-BP630932LAAS1
CSB-MP630932LAAS1
CSB-EP630932LAAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombyx mori FMRFamide-related peptides (RFa) CSB-YP630933BTT
CSB-EP630933BTT
CSB-BP630933BTT
CSB-MP630933BTT
CSB-EP630933BTT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lake Victoria marburgvirus Nucleoprotein (NP), partial CSB-YP630934LAAT
CSB-EP630934LAAT
CSB-BP630934LAAT
CSB-MP630934LAAT
CSB-EP630934LAAT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lake Victoria marburgvirus Envelope glycoprotein (GP), partial CSB-YP630935LAAQ
CSB-EP630935LAAQ
CSB-BP630935LAAQ
CSB-MP630935LAAQ
CSB-EP630935LAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana ATP-dependent zinc metalloprotease FTSH 6, chloroplastic (FTSH6), partial CSB-YP630936DOA1
CSB-EP630936DOA1
CSB-BP630936DOA1
CSB-MP630936DOA1
CSB-EP630936DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein At-4/1 (At4g26020) CSB-YP630937DOA
CSB-EP630937DOA
CSB-BP630937DOA
CSB-MP630937DOA
CSB-EP630937DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Fatty acyl-CoA reductase 8 (FAR8) CSB-YP630938DOA
CSB-EP630938DOA
CSB-BP630938DOA
CSB-MP630938DOA
CSB-EP630938DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Pentatricopeptide repeat-containing protein At2g44880 (PCMP-E9), partial CSB-YP630939DOA
CSB-EP630939DOA
CSB-BP630939DOA
CSB-MP630939DOA
CSB-EP630939DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Serine carboxypeptidase-like 22 (SCPL22) CSB-YP630940DOA
CSB-EP630940DOA
CSB-BP630940DOA
CSB-MP630940DOA
CSB-EP630940DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana BEL1-like homeodomain protein 11 (BLH11) CSB-YP630941DOA
CSB-EP630941DOA
CSB-BP630941DOA
CSB-MP630941DOA
CSB-EP630941DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Pumilio homolog 9 (APUM9), partial CSB-YP630942DOA
CSB-EP630942DOA
CSB-BP630942DOA
CSB-MP630942DOA
CSB-EP630942DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epomophorus wahlbergi Cytochrome b (MT-CYB), partial CSB-YP630943EAAQ
CSB-EP630943EAAQ
CSB-BP630943EAAQ
CSB-MP630943EAAQ
CSB-EP630943EAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>